News

FY 2012 Slightly Better than Cefic Forecast

Generics Brought Down Common Drug Prices in 2012

A. Schulman Offers to Buy Ferro for $563 Million

ECHA Launches New Public Consultation on 10 Potential SVHCs

Arkema Denies Allegations Made by Klesch

India Rules Against Bayer in Cancer Drug Patent Case

Arbitrator Sets Final Dow Chemical Payout from Kuwait Venture

Evonik Concentrates Cyanuric Chloride Business in Germany

Hikma Eyes Options for Injectables Business

Vopak Hit as Demand for Oil and Chemical Storage Falls

Russian Government Proposes that BP CEO Dudley Join Rosneft Board

U.S. Barnett Shale to Pump Natural Gas to 2050

Canada's Valeant on Hunt for More Deals

Codexis Reports Fourth Quarter and Full Year 2012 Results

QP, Shell Announce FEED Award for Al-Karaana

Bayer 2013 Outlook Slightly Below Market View

Catalent Applied Drug Delivery Institute Appoints Executive Director

US Supreme Court Rules Against Amgen in Class Action

GlaxoSmithKline Unit Joins Patent Pool for AIDS Drugs

CordenPharma Expands with ICIG Acquisition of Farchemia

BASF to Open R&D Center for Battery Materials in Japan

UCB in 2012: New Core Medicines Drive Growth

Switzerland's Roche Pledges to Open Up Access to Drug Data

FDA Halts Trials of Amgen Drug in Children, Cites Death

Potash Corp Wants to Buy Israel Chemicals Despite Obstacles

Dendreon Posts Smaller-than-expected Quarterly Loss

Croda's Profit Rises on Strong Consumer Care Sales

NBGI Private Equity Acquires Stiplastics

Reverdia Starts World’s First Large-Scale Bio-Based Succinic Acid Plant

Royalty Pharma Proposes $6.6 Billion Bid for Elan

Sinopec to Buy Stake in Chesapeake Assets for $1.02 Billion

Oxea Reports Increased Revenues and Earnings in Q4 2012

Oxea, a global supplier of Oxo Intermediates and Oxo Derivatives, today announced for the fourth quarter of 2012 a strong earnings increase compared with the fourth quarter of 2011.

Borealis Continues to Deliver Strong Results in 2012

Hungary's Richter Forms Joint Venture in China

Affymax, Takeda Recall Anemia Drug Omontys After Deaths